 |
 |
 |
 |
 |
 |
|
||||||||||||||
Select publications
Carlson RW et al. A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): A trial of the Eastern Cooperative Oncology Group. Cancer Invest 2006;24(7):677-81. Abstract
Muss HB et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293(9);1073-81. Abstract
Robert N et al. Phase III comparison of tamoxifen versus tamoxifen with ovarian
ablation in premenopausal women with axillary node-negative receptor-positive breast cancer ≤ 3 cm. Proc ASCO 2003;Abstract 16.
Shak S et al. Subtypes of breast cancer defined by standardized quantitative RT-PCR analysis of 10,618 tumors. San Antonio Breast Cancer Symposium 2006;Abstract 6118.
Sparano JA. TAILORx: Trial assigning individualized options for treatment (Rx). Clin Breast Cancer 2006;7(4):347-50. No abstract available
Strasser-Weippl K, Goss PE. Advances in adjuvant hormonal therapy for postmenopausal women. J Clin Oncol 2005;23(8):1751-9. No abstract available
Wood WC. The role of clinical trials in changing therapy for ductal carcinoma in situ. Ann Surg Oncol 2004;11(1 Suppl):24-7. Abstract
Wood WC et al. Can we select which patients with small breast cancers should receive adjuvant chemotherapy? Ann Surg 2002;235(6):859-62. Abstract
| Table of Contents | Top of Page |
Editor:
Neil Love, MD
Interviews
J Michael Dixon, MD
- Select publications
Maura N Dickler, MD
- Select publications
William C Wood, MD
- Select publications
John Mackey, MD
- Select publications
 |
 |
 |
 |
 |
